跳至主要内容
临床试验/DRKS00012532
DRKS00012532已完成不适用

Association of a comprehensive geriatric assessment and toxicity, overall survival and quality of life

Kliniken Essen-Mitte0 个研究点目标入组 208 人开始时间: 2017年10月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
208

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
65 Years 至 one(—)
性别
All

入选标准

  • Patient with histologically confirmed carcinoma or histologically confirmed aggressive B-NHL
  • -First diagnosis of cancer
  • -Age 65 years and above
  • -Estimated life expectancy of at least 3 months
  • -Informed consent
  • -Judged fit or vulnerable by assessment of the geriatric-oncologic conference
  • -Judged Unfit by assessment of the geriatric-oncologic conference

排除标准

  • -Patients with leukemia, indolent lymphoma
  • -Previous chemotherapy
  • -Unwillingness of the patient to undergo a geriatric assessment
  • -Imminent dialysis
  • -Brain metastasis
  • -Acute coronary syndrome within the last 3 months
  • -Unwillingness to participate in regular follow-up visits

研究者

发起方
Kliniken Essen-Mitte

相似试验